Literature DB >> 30183308

Palmitate-Induced Insulin Hypersecretion and Later Secretory Decline Associated with Changes in Protein Expression Patterns in Human Pancreatic Islets.

Karlfried Groebe1, Jing Cen2, Domitille Schvartz3, Ernest Sargsyan2, Azazul Chowdhury2, Kirsten Roomp4, Reinhard Schneider4, Anders Alderborn2, Jean-Charles Sanchez3, Peter Bergsten2.   

Abstract

In obese children with high circulating concentrations of free fatty acid palmitate, we have observed that insulin levels at fasting and in response to a glucose challenge were several times higher than in obese children with low concentrations of the fatty acid as well as in lean controls. Declining and even insufficient insulin levels were observed in obese adolescents with high levels of the fatty acid. In isolated human islets exposed to palmitate we have observed insulin hypersecretion after 2 days exposure. In contrast, insulin secretion from the islets was reduced after 7 days culture in the presence of the fatty acid. This study aims at identifying islet-related biological events potentially linked with the observed insulin hypersecretion and later secretory decline in these obese children and adolescents using the islet model. We analyzed protein expression data obtained from human islets exposed to elevated palmitate levels for 2 and 7 days by an improved methodology for statistical analysis of differentially expressed proteins. Protein profiling of islet samples by liquid chromatography-tandem mass spectrometry identified 115 differentially expressed proteins (DEPs). Several DEPs including sorcin were associated with increased glucose-stimulated insulin secretion in islets after 2 days of exposure to palmitate. Similarly, several metabolic pathways including altered protein degradation, increased autophagy, altered redox condition, and hampered insulin processing were coupled to the functional impairment of islets after 7 days of culture in the presence of palmitate. Such biological events, once validated in the islets, may give rise to novel treatment strategies aiming at normalizing insulin levels in obese children with high palmitate levels, which may reduce or even prevent obesity-related type 2 diabetes mellitus.

Entities:  

Keywords:  GSIS; T2DM; bioinformatic analysis; childhood obesity; differential proteomic analysis; glucose-stimulated insulin secretion; human pancreatic islets; in vitro; insulin hypersecretion; insulin hyposecretion; insulin secretion; palmitate; proteomics; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 30183308     DOI: 10.1021/acs.jproteome.8b00239

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  4 in total

1.  Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2.

Authors:  Amber Lockridge; Seokwon Jo; Eric Gustafson; Niklas Damberg; Ramkumar Mohan; Miranda Olson; Juan E Abrahante; Emilyn U Alejandro
Journal:  Cell Rep       Date:  2020-05-05       Impact factor: 9.423

2.  Combined transcriptome and proteome profiling of the pancreatic β-cell response to palmitate unveils key pathways of β-cell lipotoxicity.

Authors:  Maria Lytrivi; Kassem Ghaddar; Miguel Lopes; Victoria Rosengren; Anthony Piron; Xiaoyan Yi; Henrik Johansson; Janne Lehtiö; Mariana Igoillo-Esteve; Daniel A Cunha; Lorella Marselli; Piero Marchetti; Henrik Ortsäter; Decio L Eizirik; Miriam Cnop
Journal:  BMC Genomics       Date:  2020-08-26       Impact factor: 3.969

3.  Sorcin: a novel potential target in therapies of cancers.

Authors:  Xinyi Zhou; Xue Wu; Baoan Chen
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989

Review 4.  Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.

Authors:  Theo Battista; Annarita Fiorillo; Valerio Chiarini; Ilaria Genovese; Andrea Ilari; Gianni Colotti
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.